GL1X · GenesisL1 explorer

MolNFT v1 · #189589 · protein

Crystal structure of SARS-cov-2 main protease in complex with PF07321332 in spacegroup P212121

7VLQ · 3C-like proteinase: “Crystal structure of SARS-cov-2 main protease in complex with PF07321332 in spacegroup P212121”. X-ray diffraction, 1 ligand (4WI), 5 pockets (best druggability 0.74). MolNFT v1 #189589 on GenesisL1: 3D…

PDB
7VLQ
Type
protein
Length
596 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTC1
Ligands
4WI
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein29626% helix, 30% strandP0DTC1
B3C-like proteinase (EC 3.4.22.69)protein30027% helix, 30% strandP0DTC1

Ligands and binding sites

  • 4WI · (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18480.740.7972empty
24760.610.7586empty
31960.520.78284WI
42140.520.77304WI
5840.360.7618empty

Interfaces

1 interface between chains.

  • A–B · 971 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 7VLQ · Crystal structure of SARS-Cov-2 main protease in complex with PF07321332 in spacegroup… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.